MétaCan
Menu
Back to cohort
Record W2744776760 · doi:10.1016/j.jaad.2017.06.042

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

2017· review· en· W2744776760 on OpenAlexfundno aff
Eric L. Simpson, Marjolein de Bruin‐Weller, Carsten Flohr, Michael R. Ardern‐Jones, S. Barbarot, Mette Deleuran, Thomas Bieber, Christian Vestergaard, Sara Brown, Michael J. Cork, Aaron M. Drucker, Lawrence F. Eichenfield, R. Foelster‐Holst, Emma Guttman‐Yassky, Audrey Nosbaum, Nick J. Reynolds, Jonathan I. Silverberg, Jochen Schmitt, Marieke M.B. Seyger, Phyllis I. Spuls, Jean-Francois Stalder, John Su, Roberto Takaoka, Claudia Traidl‐Hoffmann, Jacob P. Thyssen, Jorien van der Schaft, Andreas Wollenberg, Alan D. Irvine, Amy S. Paller

Bibliographic record

VenueJournal of the American Academy of Dermatology · 2017
Typereview
Languageen
FieldMedicine
TopicDermatology and Skin Diseases
Canadian institutionsnot available
FundersSanofi GenzymeNovartis PharmaLEO PharmaLEO FondetAstellas PharmaYonsei UniversityDermiraChugai PharmaceuticalWellcome TrustRegeneron PharmaceuticalsGenentechValeant Pharmaceuticals InternationalSanofiBiotechnology and Biological Sciences Research CouncilAmgenPfizerLes Laboratories Pierre FabreMedical Research CouncilCelgeneGaldermaAstraZenecaEli Lilly and CompanyGlaxoSmithKline
KeywordsMedicineAtopic dermatitisWarrantDermatologySystemic therapyIntensive care medicineInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Although most patients with atopic dermatitis (AD) are effectively managed with topical medication, a significant minority require systemic therapy. Guidelines for decision making about advancement to systemic therapy are lacking. OBJECTIVE: To guide those considering use of systemic therapy in AD and provide a framework for evaluation before making this therapeutic decision with the patient. METHODS: A subgroup of the International Eczema Council determined aspects to consider before prescribing systemic therapy. Topics were assigned to expert reviewers who performed a topic-specific literature review, referred to guidelines when available, and provided interpretation and expert opinion. RESULTS: We recommend a systematic and holistic approach to assess patients with severe signs and symptoms of AD and impact on quality of life before systemic therapy. Steps taken before commencing systemic therapy include considering alternate or concomitant diagnoses, avoiding trigger factors, optimizing topical therapy, ensuring adequate patient/caregiver education, treating coexistent infection, assessing the impact on quality of life, and considering phototherapy. LIMITATIONS: Our work is a consensus statement, not a systematic review. CONCLUSION: The decision to start systemic medication should include assessment of severity and quality of life while considering the individual's general health status, psychologic needs, and personal attitudes toward systemic therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.031
metaresearch head score (Gemma)0.072
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.031
Threshold uncertainty score0.162

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0310.072
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.005
Bibliometrics0.0090.006
Science and technology studies0.0010.001
Scholarly communication0.0030.005
Open science0.0050.002
Research integrity0.0050.004
Insufficient payload (model declined to judge)0.0050.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.143
GPT teacher head0.395
Teacher spread0.252 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations236
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Academy of DermatologySame topicDermatology and Skin DiseasesFrench-language works237,207